Announcements
Projects
Orgs
Project Post
Articles 40
Votes 0
FierceBiotech

Authors 5

Ben Adams
Helen Floersh
FierceBiotech
James Waldron
Max Bayer
J&J's multiple myeloma combo produces 96% Carvykti-like response - FierceBiotech
~2y
Gilead and Arcus' TIGIT combo continues to show signs of life - FierceBiotech
~2y
New RNA biotech raises $300M in largest private round of 2023 - FierceBiotech
~2y
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf - FierceBiotech
~2y
UPDATED: Sarepta rewarded by Wall Street for FDA committee shocker, with accelerated nod now more likely - FierceBiotech
~2y
All the rumors are true: Syneos snapped up for $7.1B - FierceBiotech
~2y
Dual CRISPR therapy plus long-acting ART eliminates HIV in mice - FierceBiotech
~2y
Novartis prunes assets, axing 10% of pipeline programs to narrow R&D focus - FierceBiotech
~2y
Revolo drops dab of midphase data on would-be Dupixent rival - FierceBiotech
~2y
New test detects Parkinson's biomarker before movement symptoms start - FierceBiotech
~2y
Returning the complement: Protein's role in pathway could bolster new Alzheimer's approach - FierceBiotech
~2y
Pear Therapeutics exploring a sale amid hemorrhaging costs - FierceBiotech
>2y
Targeted protein degradation improves cognition and reduces Alzheimer's brain pathology in mouse models - FierceBiotech
>2y
Protalix, Chiesi edge close to potential Fabry disease approval
~5y
Another Alexion alum joins Rallybio ranks
~5y